A Biobehavioral Model of Diabetes Risk in Chinese Immigrants
NCT ID: NCT02449213
Last Updated: 2021-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
650 participants
OBSERVATIONAL
2016-03-11
2021-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Mobile Health Intervention to Reduce Diabetes Disparities in Chinese Americans
NCT03557697
Lifestyle Interventions to Reduce Diabetes Risk
NCT00006162
Personalized Behavioral Nutrition Intervention in Older AAs With T2D
NCT04533659
Prevention of Type 2 Diabetes Amongst South Asians With Central Obesity and Prediabetes
NCT02949739
Identifying Risk for Diabetes and Heart Disease in Women
NCT01809288
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* migration from Asia in adulthood (aged 18 years or older); and
* age 35-65 years
Exclusion Criteria
* Self-reported conditions of cancer, auto-immune disorders, HIV, or psychiatric illness
* Use of medications that may impact study outcomes (e.g., steroidal or non-steroidal anti-inflammatory medications)
* Inability to provide informed consent.
35 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fox Chase Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolyn Y. Fang, PhD
Role: PRINCIPAL_INVESTIGATOR
Fox Chase Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-8006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.